We agree with the report by Herrera et al 1 demonstrating that antiangiotensin II type-1 receptor (AT 1 R) antibodies that are commonly used exhibit nonspecific binding that may lead to erroneous results. Because only 3 AT 1 R antibodies were used in the study, we would like to share our findings to support their conclusion.
In contrast, no specific difference was observed among the cell lysates immunoblotted with 3 distinct AT 1 R antibodies, which should have detected rat AT 1A R according to the manufacturers ( Figure) .
Herrera et al 1 used mouse tissues and cells expressing mouse AT 1A R for their experiments. Our data support and expand the findings by including rat AT 1A R and adding 2 other frequently used AT 1 R antibodies. Researchers must be aware that commercially available AT 1 R antibodies and antibodies against other G protein-coupled receptors may not be specific enough to quantify the receptor expression. To publish an article using an AT 1 R antibody, it should be accompanied by sufficient evidence to support the specificity. We also encourage the antibody manufacturers to include rigorous confirmation before commercialization.
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